{"schema_version":"secwatch.filing_event.v1","accession":"0001667011-23-000021","form_type":"8-K","ticker":"AIP","cik":"0001667011","company_name":"Arteris, Inc.","filed_at":"2023-08-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.786242+00:00","generated_at":"2026-06-12T08:36:13.619452+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Arteris Q2 revenue $14.7M beats guidance; ACV+TTM royalties +13% YoY; Q3 rev guide $12.5-13.5M","bullets":["Revenue $14.7M exceeded guidance; ACV+TTM royalties $58.2M (+13% YoY, +21% ex-DJI).","GAAP net loss $9.2M ($0.26/share); non-GAAP net loss $4.7M ($0.13/share); non-GAAP op loss $4.2M.","Q3 guidance: revenue $12.5-13.5M, ACV+TTM $57-61M, non-GAAP op loss margin 42-62%.","Added 12 active customers; 22 design starts (12 AI-enabled); deals with three top-10 semis.","Majority of revenue contracts expected to be recognized ratably going forward."],"urls":{"canonical":"https://secwatch.observer/filing/0001667011-23-000021","json":"https://secwatch.observer/filing/0001667011-23-000021.json","markdown":"https://secwatch.observer/filing/0001667011-23-000021.md","text":"https://secwatch.observer/filing/0001667011-23-000021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1667011/000166701123000021/0001667011-23-000021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1667011/000166701123000021/aip-20230803.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T08:36:13.619452+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6c9eb294230ccdf82b4fa20774061037f8420bf4","claim":"Arteris, Inc. reported the quarter ended June 30, 2023 results: revenue $14.7 million, net income Net loss of $9.2 million or $0.26 per share, EPS $0.26 per share. Guidance raised.","evidence_excerpt":"Arteris.\" Second Quarter 2023 Financial Highlights: • Annual Contract Value (ACV) and Trailing-twelve-month (TTM) royalties of $58.2 million, up 13% year-over-year • Revenue of $14.7 million, exceeding the top end of our guidance • Remaining performance obligation (RPO) of $65.1 million, up $7.8 million sequentially • Operating loss of $8.7 million or 59% of revenue","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1667011/000166701123000021/0001667011-23-000021-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended June 30, 2023"},{"label":"Revenue","value":"$14.7 million"},{"label":"Net income","value":"Net loss of $9.2 million or $0.26 per share"},{"label":"EPS","value":"$0.26 per share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}